metformin SR steady state study (+glucose) [Design Issues]

posted by jagankm  – 2011-04-26 15:22 (5537 d 11:55 ago) – Posting: # 6939
Views: 6,159

hello sir,
i got one issue while designing BE study for metformin SR tablets. the issue is administration of 20% glucose containing water every 15 min till 4hrs after administration of dose. this is given in US draft guidlines of metformin. but when we plan a BE study for EMEA countries, is it necessary to fallow these guidlines or any specific EMEA guidlines available regarding administration of glucose solution.If we fallow US draft guidlines for EMEA BE study any problem with regulatory body?

could you share your experience in this regards

i will be thankfull to you sir,

jagan mohan k

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
143 visitors (0 registered, 143 guests [including 43 identified bots]).
Forum time: 03:18 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5